|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Service de Pneumologie et Réanimation Respiratoire (Drs. Thabut, Dauriat, Stern, Marrash-Chahla, and Mal), and Service de Cardiologie (Dr. Logeart), Hôpital Beaujon, Clichy; and Service de Pneumologie (Dr. Lévy), Centre Hospitalier de Bourges, Bourges, France.
Correspondence to: Hervé Mal, MD, Service de Pneumologie et Réanimation Respiratoire, Hôpital Beaujon, 100 Bd du Général Leclerc 92110, Clichy, France; e-mail: herve.mal{at}bjn.ap-hop-paris.fr
Study objectives: To assess the pulmonary hemodynamic characteristics in COPD candidates for lung volume reduction surgery (LVRS) or lung transplantation (LT).
Design: Retrospective study.
Setting: One center in France.
Patients: Two hundred fifteen patients with severe COPD who underwent right-heart catheterization before LVRS or LT.
Results: Mean age was 54.6 years. Pulmonary function test results were as follows: FEV1, 24.3% predicted; total lung capacity, 128.3% predicted; residual volume, 259.7% predicted. Mean pulmonary artery pressure (PAPm) was 26.9 mm Hg. Pulmonary hypertension (PAPm > 25 mm Hg) was present in 50.2% and was moderate (PAPm, 35 to 45 mm Hg) or severe (PAPm > 45 mm Hg) in 9.8% and in 3.7% of patients, respectively. Cardiac index was low normal. PAPm was related to PaO2 and alveolar-arterial oxygen gradient in multivariate analysis. Cluster analysis identified a subgroup of atypical patients (n = 16, 7.4%) characterized by moderate impairment of the pulmonary mechanics (mean FEV1, 48.5%) contrasting with high level of pulmonary artery pressure (PAPm, 39.8 mm Hg), and severe hypoxemia (mean PaO2, 46.2 mm Hg).
Conclusion: While pulmonary hypertension is observed in half of the COPD patients with advanced disease, moderate-to-severe pulmonary hypertension is not a rare event in these patients. We individualized a subgroup of patients presenting with a predominant vascular disease that could potentially benefit from vasodilators.
Key Words: COPD hemodynamics pulmonary hypertension
This article has been cited by other articles:
![]() |
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez Pulmonary Diseases and the Heart Circulation, December 18, 2007; 116(25): 2992 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Leuchte, R. A. Baumgartner, M. E. Nounou, M. Vogeser, C. Neurohr, M. Trautnitz, and J. Behr Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |